🇺🇸 FDA
Patent

US 9642859

Use of capsazepine and analogs thereof to treat cancer

granted A61KA61K31/55A61K45/06

Quick answer

US patent 9642859 (Use of capsazepine and analogs thereof to treat cancer) held by The Board of Regents of the University of Texas System expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/55, A61K45/06, A61K9/0019, A61P